40 results
6-K
EX-99.1
ACIU
AC Immune SA
21 May 24
Current report (foreign)
8:00am
to be approved by shareholders. This year’s Annual Report again contains our Environmental, Social and Governance Report. In review, 2023 brought welcome … of the Compensation, Nomination & Corporate Governance Committee 3. Re - election of the Statutory Auditors 4. Re - election of the Independent Proxy 6. Changes
6-K
EX-99.2
ACIU
AC Immune SA
21 May 24
Current report (foreign)
8:00am
For Against Abstain 5.2.c Douglas Williams F or Against Abstain 5.2. Re - elections of Members of the Compensation, Nomination & Corporate Governance
424B5
ACIU
AC Immune SA
15 Dec 23
Prospectus supplement for primary offering
5:27pm
on certain home country governance practices rather than the corporate governance requirements of Nasdaq.
We are a foreign private issuer … . As a result, in accordance with Nasdaq Listing Rule 5615(a)(3), we comply with home country (in this case, Swiss) governance requirements and certain
6-K
mqqt0
26 Jun 23
Current report (foreign)
8:40am
6-K
EX-99.1
g0wjfctezf2v
26 Jun 23
Current report (foreign)
8:40am
6-K
EX-99.1
gi0oix82 zeg00
24 May 23
Invitation to the Annual General Meeting 2023 To the Shareholders of AC Immune SA
4:07pm
6-K
EX-99.3
g5rra6of97hp7io8o
24 May 23
Invitation to the Annual General Meeting 2023 To the Shareholders of AC Immune SA
4:07pm
6-K
q622y9sd3cvxyt
24 Jun 22
Current report (foreign)
5:29pm
6-K
EX-99.1
t45p nwadsf
25 May 22
Notice of the Annual General Meeting 2022 To the Shareholders of AC Immune SA
4:29pm
6-K
EX-99.2
n0s20phs
25 May 22
Notice of the Annual General Meeting 2022 To the Shareholders of AC Immune SA
4:29pm
6-K
EX-99.4
apksw flp1
22 Mar 22
AC Immune Reports Full Year 2021 Financial Results and Provides Corporate Update
7:03am
6-K
g3t7m06r5izmzeq7
25 Jun 21
Current report (foreign)
4:31pm
6-K
EX-99.1
kcz 742er
21 May 21
Notice of the Annual General Meeting 2021 To the Shareholders of AC Immune SA 1
8:55am
6-K
EX-99.4
opb5 ba1js
23 Mar 21
AC Immune Reports Full-Year 2020 Financial Results and Provides 2021 R&D Outlook
9:06am
6-K
jct30loynvx085w9f
26 Jun 20
Current report (foreign)
4:51pm
6-K
EX-99.1
50k0l egdrll7dj8
22 May 20
Invitation to the Ordinary Shareholders' Meeting
8:40am